These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 15586571
1. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog. Preziosi R, Morini M, Sarli G. J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571 [Abstract] [Full Text] [Related]
2. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V. Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137 [Abstract] [Full Text] [Related]
4. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors. Romanucci M, Massimini M, Ciccarelli A, Malatesta D, Bongiovanni L, Gasbarre A, Della Salda L. Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984 [Abstract] [Full Text] [Related]
5. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis. Vascellari M, Giantin M, Capello K, Carminato A, Morello EM, Vercelli A, Granato A, Buracco P, Dacasto M, Mutinelli F. Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539 [Abstract] [Full Text] [Related]
11. Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine. Thamm DH, Weishaar KM, Charles JB, Ehrhart EJ. Vet Comp Oncol; 2020 Jun; 18(2):169-175. PubMed ID: 31365175 [Abstract] [Full Text] [Related]
14. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors. Sabattini S, Bettini G. Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469 [Abstract] [Full Text] [Related]